X |
Filing Date |
Trade Date |
Ticker |
Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2021-02-16 | CUE | Pienta Kenneth | Chief Medical Officer | S - Sale+OE | $15.13 | -20,274 | 2,000 | -91% | -$306,767 | |||||
| AD | 2021-01-20 | CUE | Pienta Kenneth | Chief Medical Officer | S - Sale+OE | $15.07 | -2,720 | 2,000 | -58% | -$40,980 | |||||
2021-01-20 | CUE | Pienta Kenneth | Chief Medical Officer | P - Purchase | $15.07 | +2,720 | 4,720 | +136% | +$40,980 | ||||||
2020-11-24 | CUE | Fletcher Aaron G.L. | Dir | P - Purchase | $12.64 | +6,548 | 173,867 | +4% | +$82,776 | ||||||
| M | 2020-09-29 | CUE | Gray Cameron | Dir | P - Purchase | $15.15 | +10,000 | 677,500 | +1% | +$151,500 | |||||
| AD | 2020-08-05 | CUE | Sandercock Colin | SVP, GC, Sec | S - Sale+OE | $20.00 | -13,374 | 17,125 | -44% | -$267,480 | |||||
| D | 2020-08-05 | CUE | Sandercock Colin | SVP, GC, Sec | S - Sale+OE | $20.00 | -13,274 | 17,125 | -44% | -$265,480 | |||||
| D | 2020-08-05 | CUE | Suri Anish | Pres, CSO | S - Sale+OE | $20.01 | -800 | 34,558 | -2% | -$16,008 | |||||
| DM | 2020-08-03 | CUE | Sandercock Colin | SVP, GC, Sec | S - Sale+OE | $20.00 | -6,626 | 17,125 | -28% | -$132,530 | |||||
| DM | 2020-08-03 | CUE | Suri Anish | Pres, CSO | S - Sale+OE | $20.02 | -6,200 | 34,558 | -15% | -$124,114 | |||||
2020-06-24 | CUE | Fletcher Aaron G.L. | Dir | P - Purchase | $24.88 | +7,500 | 167,319 | +5% | +$186,572 | ||||||
| AM | 2019-06-07 | CUE | Sandercock Colin | SVP, GC, Sec | P - Purchase | $7.90 | +15,125 | 17,125 | +756% | +$119,433 | |||||
| M | 2019-12-27 | CUE | Marlett Christopher A | Dir | S - Sale | $16.28 | -24,700 | 768,503 | -3% | -$402,209 | |||||
| M | 2019-12-23 | CUE | Marlett Christopher A | Dir | S - Sale | $17.20 | -36,647 | 793,203 | -4% | -$630,352 | |||||
| M | 2019-12-17 | CUE | Marlett Christopher A | Dir | S - Sale | $15.94 | -24,732 | 829,850 | -3% | -$394,114 | |||||
2019-06-21 | CUE | Passeri Daniel R | CEO, Pres | P - Purchase | $7.26 | +1,377 | 51,977 | +3% | +$9,997 | ||||||
| M | 2019-06-06 | CUE | Sandercock Colin | SVP, GC, Sec | P - Purchase | $7.83 | +16,938 | 16,938 | New | +$132,658 | |||||
2019-06-06 | CUE | Passeri Daniel R | CEO, Pres | P - Purchase | $6.90 | +3,000 | 50,600 | +6% | +$20,700 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |